Minerva Neurosciences | NERV - درآمد خالص





درآمد خالص تغییر دادن تاریخ
Acadia Pharmaceuticals USD 273.57M 201.79M 2025-12
Adma Biologics USD 49.38M 12.95M 2025-12
ALKERMES USD 49.34M 33.42M 2025-12
Alterity Therapeutics Limited AUD -5.77M 2.26M 2023-06
AstraZeneca USD 2.33B 207M 2025-12
BioCryst Pharmaceuticals USD 245.84M 232.95M 2025-12
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Cipla INR 6.76B 6.75B 2025-12
Clal Biotechnology ILS -6.17M 15.56M 2022-12
Compugen USD 56.84M 63.82M 2025-12
CSL USD 401M 96.5M 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
Esperion Therapeutics USD 61.83M 93.16M 2025-12
GlaxoSmithKline GBP 636M 1.38B 2025-12
Grifols EUR 114.37M 34.03M 2025-12
Halozyme Therapeutics USD -141.59M 316.82M 2025-12
Ionis Pharmaceuticals USD -229M 100.39M 2025-12
J&J USD 5.12B 36M 2025-12
Merck USD 2.96B 2.82B 2025-12
Minerva Neurosciences USD 1.44M 21.07M 2024-12
Neurocrine Biosciences USD 209.5M 102M 2025-09
Novartis USD 2.41B 1.52B 2025-12
Novavax USD 17.53M 219.91M 2025-12
Pfizer USD -1.65B 5.19B 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
Sanofi EUR -801M 3.6B 2025-12
Takeda JPY 103.64B 115.44B 2025-12
Vanda Pharmaceuticals USD -18.9M 13.58M 2024-12